EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase II)

Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial

Michelle S Troche iD, James A Curtis iD, Jordanna S Sevitz iD, Avery E Dakin iD, Sarah E Perry iD, James C Borders iD, Alessandro A Grande iD, Yuhan Mou iD, Nora Vanegas-Arroyave iD, Karen W Hegland iD

Movement Disorders · 2023-02 · 38 (2) · 201-211

DOI: 10.1002/mds.29268 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, online erschienen am 07.11.2022. Verfasst von Michelle S Troche und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, New York…. Hauptthemen laut MEDLINE: Parkinson Disease, Deglutition Disorders. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Disorders of airway protection (cough and swallowing) are pervasive in Parkinson's disease (PD) resulting in a high incidence of aspiration pneumonia and death. However, there are no randomized controlled trials comparing strength and skill‐based approaches to improve airway protection in PD.

Objectives

The aim of this study was to compare expiratory muscle strength training (EMST) and sensorimotor training for airway protection (smTAP) to improve cough‐related outcomes in people with PD.

Methods

Participants with PD and dysphagia were recruited for this prospective phase II randomized‐blinded controlled clinical trial. Participants completed baseline assessment, 5 weeks of EMST or smTAP, and a post‐training assessment. Primary outcome measures included maximum expiratory pressure (MEP) and voluntary cough peak expiratory flow rate (PEFR). Mixed effects models were used to assess the effects of EMST and smTAP on outcomes.

Results

A total of 65 participants received either EMST ( n = 34) or smTAP ( n = 31). MEP improved from pre‐ to post‐treatment for smTAP ( P < 0.001, d = 0.19) and EMST ( P < 0.001, d = 0.53). Voluntary PEFR increased from pre‐ to post‐treatment for smTAP ( P < 0.001, d = 0.19) and EMST ( P < 0.001, d = 0.06). Moreover, reflex cough PEFR ( P < 0.001, d = 0.64), reflex cough expired volume ( P < 0.001, d = 0.74), and urge to cough ( P = 0.018, OR = 2.70) improved for the smTAP group but not for the EMST group.

Conclusions

This clinical trial confirmed the efficacy of smTAP to improve reflex and voluntary cough function, above and beyond EMST, the current gold standard. © 2022 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDeglutition DisordersHumansCoughProspective StudiesRespiratory MusclesDeglutition

Stichwörter der Autor:innen

Parkinson's diseasecoughdysphagiadystussiarehabilitation

Autor:innen und Institutionen

  • Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, New York, USA.
  • Division of Movement Disorders, Department of Neurology, Columbia University Medical Center, New York, New York, USA.
  • University of Canterbury Rose Centre for Stroke Recovery and Research at St. George's Medical Centre, Christchurch, New Zealand.
  • Department of Medicine, University of Otago, Christchurch, New Zealand.
  • New Zealand Brain Research Institute, Christchurch, New Zealand.
  • Department of Statistics, Columbia University, New York, New York, USA.

ORCID-Profile: Michelle S Troche, James A Curtis, Jordanna S Sevitz, Avery E Dakin, Sarah E Perry, James C Borders, Alessandro A Grande, Yuhan Mou, Nora Vanegas-Arroyave, Karen W Hegland

Zitieren

APA

Troche, M. S., Curtis, J. A., Sevitz, J. S., Dakin, A. E., Perry, S. E., Borders, J. C., Grande, A. A., Mou, Y., Vanegas-Arroyave, N., & Hegland, K. W. (2023). Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial. Movement Disorders, 38(2), 201-211. https://doi.org/10.1002/mds.29268

Vancouver

Troche MS, Curtis JA, Sevitz JS, Dakin AE, Perry SE, Borders JC, et al. Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial. Movement Disorders. 2023;38(2):201-211. doi:10.1002/mds.29268

BibTeX
@article{Troche2023,
  author = {Troche, Michelle S and Curtis, James A and Sevitz, Jordanna S and Dakin, Avery E and Perry, Sarah E and Borders, James C and Grande, Alessandro A and Mou, Yuhan and Vanegas-Arroyave, Nora and Hegland, Karen W},
  title = {Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial},
  journal = {Movement Disorders},
  year = {2023},
  volume = {38},
  number = {2},
  pages = {201--211},
  doi = {10.1002/mds.29268}
}
Kostenlos starten →